These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo. Yang J; Li X; Al-Lamki RS; Southwood M; Zhao J; Lever AM; Grimminger F; Schermuly RT; Morrell NW Circ Res; 2010 Jul; 107(2):252-62. PubMed ID: 20522807 [TBL] [Abstract][Full Text] [Related]
5. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension. Tojais NF; Cao A; Lai YJ; Wang L; Chen PI; Alcazar MAA; de Jesus Perez VA; Hopper RK; Rhodes CJ; Bill MA; Sakai LY; Rabinovitch M Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1559-1569. PubMed ID: 28619995 [TBL] [Abstract][Full Text] [Related]
6. Failure of bone morphogenetic protein receptor trafficking in pulmonary arterial hypertension: potential for rescue. Sobolewski A; Rudarakanchana N; Upton PD; Yang J; Crilley TK; Trembath RC; Morrell NW Hum Mol Genet; 2008 Oct; 17(20):3180-90. PubMed ID: 18647753 [TBL] [Abstract][Full Text] [Related]
7. BRCC3 Regulation of ALK2 in Vascular Smooth Muscle Cells: Implication in Pulmonary Hypertension. Shen H; Gao Y; Ge D; Tan M; Yin Q; Wei TW; He F; Lee TY; Li Z; Chen Y; Yang Q; Liu Z; Li X; Chen Z; Yang Y; Zhang Z; Thistlethwaite PA; Wang J; Malhotra A; Yuan JX; Shyy JY; Gong K Circulation; 2024 Jul; 150(2):132-150. PubMed ID: 38557054 [TBL] [Abstract][Full Text] [Related]
9. Id proteins are critical downstream effectors of BMP signaling in human pulmonary arterial smooth muscle cells. Yang J; Li X; Li Y; Southwood M; Ye L; Long L; Al-Lamki RS; Morrell NW Am J Physiol Lung Cell Mol Physiol; 2013 Aug; 305(4):L312-21. PubMed ID: 23771884 [TBL] [Abstract][Full Text] [Related]
10. Dysregulated Smooth Muscle Cell BMPR2-ARRB2 Axis Causes Pulmonary Hypertension. Wang L; Moonen JR; Cao A; Isobe S; Li CG; Tojais NF; Taylor S; Marciano DP; Chen PI; Gu M; Li D; Harper RL; El-Bizri N; Kim YM; Stankunas K; Rabinovitch M Circ Res; 2023 Mar; 132(5):545-564. PubMed ID: 36744494 [TBL] [Abstract][Full Text] [Related]
11. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension. Yang X; Long L; Southwood M; Rudarakanchana N; Upton PD; Jeffery TK; Atkinson C; Chen H; Trembath RC; Morrell NW Circ Res; 2005 May; 96(10):1053-63. PubMed ID: 15845886 [TBL] [Abstract][Full Text] [Related]
12. Combination Therapy with STAT3 Inhibitor Enhances SERCA2a-Induced BMPR2 Expression and Inhibits Pulmonary Arterial Hypertension. Bisserier M; Katz MG; Bueno-Beti C; Brojakowska A; Zhang S; Gubara S; Kohlbrenner E; Fazal S; Fargnoli A; Dorfmuller P; Humbert M; Hata A; Goukassian DA; Sassi Y; Hadri L Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502015 [TBL] [Abstract][Full Text] [Related]
13. Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation. Tian W; Jiang X; Sung YK; Shuffle E; Wu TH; Kao PN; Tu AB; Dorfmüller P; Cao A; Wang L; Peng G; Kim Y; Zhang P; Chappell J; Pasupneti S; Dahms P; Maguire P; Chaib H; Zamanian R; Peters-Golden M; Snyder MP; Voelkel NF; Humbert M; Rabinovitch M; Nicolls MR Circulation; 2019 Oct; 140(17):1409-1425. PubMed ID: 31462075 [TBL] [Abstract][Full Text] [Related]
14. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension. Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795 [TBL] [Abstract][Full Text] [Related]
15. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension. Gomez-Puerto MC; van Zuijen I; Huang CJ; Szulcek R; Pan X; van Dinther MA; Kurakula K; Wiesmeijer CC; Goumans MJ; Bogaard HJ; Morrell NW; Rana AA; Ten Dijke P J Pathol; 2019 Nov; 249(3):356-367. PubMed ID: 31257577 [TBL] [Abstract][Full Text] [Related]
16. SMAD1 deficiency in either endothelial or smooth muscle cells can predispose mice to pulmonary hypertension. Han C; Hong KH; Kim YH; Kim MJ; Song C; Kim MJ; Kim SJ; Raizada MK; Oh SP Hypertension; 2013 May; 61(5):1044-52. PubMed ID: 23478097 [TBL] [Abstract][Full Text] [Related]
17. PPARγ-p53-Mediated Vasculoregenerative Program to Reverse Pulmonary Hypertension. Hennigs JK; Cao A; Li CG; Shi M; Mienert J; Miyagawa K; Körbelin J; Marciano DP; Chen PI; Roughley M; Elliott MV; Harper RL; Bill MA; Chappell J; Moonen JR; Diebold I; Wang L; Snyder MP; Rabinovitch M Circ Res; 2021 Feb; 128(3):401-418. PubMed ID: 33322916 [TBL] [Abstract][Full Text] [Related]
19. Deletion of the sequence encoding the tail domain of the bone morphogenetic protein type 2 receptor reveals a bone morphogenetic protein 7-specific gain of function. Leyton PA; Beppu H; Pappas A; Martyn TM; Derwall M; Baron DM; Galdos R; Bloch DB; Bloch KD PLoS One; 2013; 8(10):e76947. PubMed ID: 24116187 [TBL] [Abstract][Full Text] [Related]
20. Abnormal trafficking of endogenously expressed BMPR2 mutant allelic products in patients with heritable pulmonary arterial hypertension. Frump AL; Lowery JW; Hamid R; Austin ED; de Caestecker M PLoS One; 2013; 8(11):e80319. PubMed ID: 24224048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]